AYTU BIOSCIENCE
Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated conditions with a focus on urological indications and related conditions. Aytu BioScience is initially concentrating on male sexual dysfunction and male infertility and will seek expansion opportunities in other urological indications.
AYTU BIOSCIENCE
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2002-01-01
Address:
Englewood, Colorado, United States
Country:
United States
Website Url:
http://www.aytubio.com
Total Employee:
101+
Status:
Active
Contact:
1(720) 437-6580
Email Addresses:
[email protected]
Total Funding:
52.48 M USD
Technology used in webpage:
Euro Amazon HSTS IPv6 Nginx Google Google Cloud Apple Mobile Web App Capable Common Name Invalid Amazon Virginia Region
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Assuré Medical
Assuré Medical is a urethral care company focused on developing non-antibiotic, patient-led solutions for chronic urethral conditions.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-10 | Neos Therapeutics | Neos Therapeutics acquired by Aytu BioScience | 44.9 M USD |
| 2019-09-12 | Innovus Pharmaceuticals | Innovus Pharmaceuticals acquired by Aytu BioScience | N/A |
| 2017-05-09 | Nuelle | Nuelle acquired by Aytu BioScience | N/A |
Investors List
Eclipse Business Capital
Eclipse Business Capital investment in Post-IPO Debt - Aytu BioScience
Stonepine Capital Management
Stonepine Capital Management investment in Post-IPO Equity - Aytu BioScience
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Aytu BioScience
Avenue Capital Group
Avenue Capital Group investment in Post-IPO Debt - Aytu BioScience
Official Site Inspections
http://www.aytubio.com Semrush global rank: 3.59 M Semrush visits lastest month: 3.59 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aytu BioScience"
About - Aytu BioPharma
At Merz, Mr. Donofrio was accountable for financial performance, cost management, business development and strategic business planning and analysis for the finance organization in …See details»
Aytu BioPharma - Crunchbase Company Profile
Contact Email [email protected] Phone Number 1(720) 437-6580 Aytu …See details»
Corporate Governance - Aytu BioPharma
Our board of directors, senior executive officers, and senior financial executives adhere to a high standard of ethics and business practices at all times, and our management team sets a …See details»
Aytu BioPharma - Overview, News & Similar companies - ZoomInfo
Aytu BioScience has announced that the Chief Financial Officer has left the organization to join Achieve Life Sciences as Chief Financial Officer. ... Phone number: (720) 437-6580 Website: …See details»
Aytu BioPharma - Craft
Oct 29, 2024 Aytu BioPharma is a specialty pharmaceutical company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on …See details»
Working At Aytu BioPharma: Company Overview and Culture
Mar 14, 2024 aytubio.com. Organization Type. Public. Social Media. Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated …See details»
Home - Aytu BioPharma
Aytu BioPharma, Inc. Denver Corporate Center III 7900 E. Union Avenue, Suite 920 Denver, CO 80237 +1 (855) AYTU BIO (+1 855-298-8246)See details»
Nominating and Governance Committee Charter - Aytu BioPharma
Organization. The Nominating and Governance Committee (the “Committee”) of the Board of Directors of Aytu BioPharma, Inc. (the “Company”) was established pursuant to Article II, …See details»
AYTU BioScience, Inc. NASDAQ: AYTU - Aytu BioPharma
Commercial organization to over 150 people across sales, marketing, payer markets, distribution, commercial operations, and national accounts. In less than four years, Arbor grew from a …See details»
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational …
Nov 6, 2024 Aytu BioPharma, Inc., a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its first quarter of fiscal …See details»
Audit Committee Charter - Aytu BioPharma - investors.aytubio.com
Jul 26, 2016 Consider the annual financial statements and determine whether they are consistent with the information known to Committee members. Discuss judgmental areas such …See details»
Governance & Compliance – Aytu BioPharma
To anonymously report any known or suspected violation of our internal compliance program, ethical commitments, responsibility charters or other applicable laws, rules or regulations, call …See details»
Aytu BioPharma to Participate in the Lytham Partners 2025
Jan 6, 2025 DENVER, CO / ACCESSWIRE / January 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on …See details»
Investor Relations - Aytu BioPharma
Aytu BioPharma, Inc. Denver Corporate Center III. 7900 E. Union Avenue. Suite 920 Denver, CO 80237 USA +1 (855) AYTU BIO (+1 855-298-8246)See details»
About - Aytu BioPharma
At Merz, Mr. Donofrio was accountable for financial performance, cost management, business development and strategic business planning and analysis for the finance organization in …See details»
ESG Committee Charter - Aytu BioPharma
Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions.See details»
AYTU BioScience, Inc. OTCQX: AYTU - Aytu BioPharma
Www.aytubio.com Industry: Specialty Pharmaceuticals, Life Sciences Year End: June 30 SHARE DISTRIBUTION Outstanding: 4.0 million STOCK SUMMARY Symbol: OTCQX:AYTUD Price: …See details»
Compensation Committee Charter - Aytu BioPharma
Jul 26, 2016 Organization. The Compensation Committee (the “Committee”) of the Board of Directors of Aytu BioPharma, Inc. (the “Company”) was established pursuant to Article II, …See details»
Pipeline - Aytu BioPharma
Aytu BioPharma, Inc. Denver Corporate Center III 7900 E. Union Avenue, Suite 920 Denver, CO 80237 +1 (855) AYTU BIO (+1 855-298-8246)See details»
Aytu BioPharma Announces Closing of Upsized At the Market …
1 day ago Aytu enters the over $22 billion United States prescription major depressive disorder ("MDD") market with the first-in-class oral selective serotonin 5HT1a receptor agonist for …See details»